Together we are beating cancer

Donate now

Emma Smith

Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
Showing 12 out of 73 results
Blood test

Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening. Blood tests, breath studies and better CT scans could all help detect lung cancers earlier. We investigate the latest research that could inform lung screening.

by Emma Smith | Analysis | 6 December 2018

6 December 2018

DNA strand double helix

By studying small differences in our DNA, called SNPs, our scientists are showing how these could be used to help prevent cancer in the future. By studying small differences in our DNA, called SNPs, our scientists are showing how these could be used to help prevent cancer in the future.

by Emma Smith | Analysis | 17 May 2018

17 May 2018

Research from the US provides evidence of the harm of patients choosing alternative therapy and declining conventional treatments and the impact on survival. Research from the US provides evidence of the harm of patients choosing alternative therapy and declining conventional treatments and the impact on survival.

by Emma Smith | Analysis | 1 November 2017

1 November 2017

Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer. Our research has led to new clinical trials testing a combination of hormone therapies in women with early, double-positive breast cancer.

by Emma Smith | Analysis | 5 May 2017

5 May 2017

T cell

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma. A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

by Emma Smith | Analysis | 3 May 2017

3 May 2017

A photo of three nurses.

We're backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials. We're backing a new project that could boost our understanding of pancreatic cancer and increase opportunities for patients to join clinical trials.

by Emma Smith | Analysis | 24 March 2017

24 March 2017

In the second part of our World Cancer Day series, we take a look at cervical cancer rates in different parts of the world. Read on to find out what can be done to prevent the disease in the future. In the second part of our World Cancer Day series, we take a look at cervical cancer rates in different parts of the world. Read on to find out what can be done to prevent the disease in the future.

by Emma Smith | Analysis | 8 February 2017

8 February 2017

Earth

For this year’s World Cancer Day we're looking at how the rates of 4 types of cancer vary around the world, and why. For this year’s World Cancer Day we're looking at how the rates of 4 types of cancer vary around the world, and why.

by Emma Smith | Analysis | 4 February 2017

4 February 2017